Quanticate announces Dr. Daniel Chapple as the company’s Vice President of Business Development and Marketing. Quanticate will leverage his business development leadership and extensive knowledge of the clinical CRO space, including full service CROs, specialist BPOs and solutions expertise in the pharmaceutical, biotechnology and medical device sectors.
“Daniel’s customer-focused orientation, self-awareness, and strong business acumen skills make him a good fit as part of our executive management team,” said David Underwood the Chairmen and CEO. “This is an exciting time at Quanticate as we are growing our operations in the US and India to support our teams already in place in the UK, Poland and South Africa. Daniel will help to streamline our approach to working across these regions to support our clients at the functional and task level due to his strong background.”Quanticate announces Dr. Daniel Chapple as the company’s Vice President of Business Development and Marketing.
The full press release can be found here.
